東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Decreased JMJD3 Expression in Mesenc...

Zhao, Wei.

Linked to FindBook

Google Book

Amazon

博客來

Decreased JMJD3 Expression in Mesenchymal Stem Cells Contributes to Long-term Suppression of Osteoblast Differentiation in Multiple Myeloma.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Decreased JMJD3 Expression in Mesenchymal Stem Cells Contributes to Long-term Suppression of Osteoblast Differentiation in Multiple Myeloma./
Author:	Zhao, Wei.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2018,
Description:	139 p.
Notes:	Source: Dissertations Abstracts International, Volume: 80-02, Section: B.
Contained By:	Dissertations Abstracts International80-02B.
Subject:	Biochemistry. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10827420
ISBN:	9780438154933

Decreased JMJD3 Expression in Mesenchymal Stem Cells Contributes to Long-term Suppression of Osteoblast Differentiation in Multiple Myeloma.
Zhao, Wei.

Decreased JMJD3 Expression in Mesenchymal Stem Cells Contributes to Long-term Suppression of Osteoblast Differentiation in Multiple Myeloma. - Ann Arbor : ProQuest Dissertations & Theses, 2018 - 139 p.

Source: Dissertations Abstracts International, Volume: 80-02, Section: B.

Thesis (Ph.D.)--Indiana University - Purdue University Indianapolis, 2018.

This item must not be sold to any third party vendors.

Multiple myeloma (MM) is the most frequent cancer to involve the skeleton, with over 80% of myeloma patients developing lytic bone disease (MMBD). Importantly, MM-associated bone lesions rarely heal even when patients are in complete remission. Bone marrow stromal cells (BMSCs) isolated from MM patients have a distinct genetic profile and an impaired osteoblast (OB) differentiation capacity when compared to BMSCs from healthy donors. Utilizing an in vivo model of MMBD and patient samples, we showed that BMSCs from tumor-bearing bones failed to differentiate into OBs weeks after removal of MM cells. Both Runx2 and Osterix, the master transcription factors for OB differentiation, remained suppressed in these BMSCs. However, the molecular mechanisms for MM-induced long-term OB suppression are poorly understood. We characterized both Runx2 and Osterix promoters in murine pre-osteoblast MC4 cells by chromatin immunoprecipitation (ChIP). The transcriptional start sites (TSSs) of Runx2 and Osterix in untreated MC4 cells were co-occupied by transcriptionally active histone 3 lysine 4 tri-methylation (H3K4me3) and transcriptionally repressive histone 3 lysine 27 tri-methylation (H3K27me3), termed the "bivalent domain". These bivalent domains became transcriptionally silent with increasing H3K27me3 levels when MC4 cells were co-cultured with MM cells or treated with TNF-α, an inflammatory cytokine increased in MM bone marrow microenvironment. The increasing H3K27me3 levels induced by MM cells or TNF-α were associated with the downregulation of the H3K27 demethylase JMJD3 in MC4 cells and murine BMSCs. Knockdown of JMJD3 in MC4 cells was sufficient to inhibit OB differentiation. Further, ectopic overexpression of JMJD3 in MC4 cells partially rescued the suppression of osteoblast differentiation induced by TNF-α. We also found that pre-incubation of MC4 cells with the NF-kB inhibitor quinazoline (QNZ) before TNF-α treatment prevented the downregulation of JMJD3. In agreement with our in vitro findings, BMSCs from MM patients had persistently decreased JMJD3 expression compared to healthy BMSCs. Our findings together demonstrate that decreased JMJD3 expression in BMSCs contributes to the long-term OB suppression in MMBD by remodeling histone landscapes at the Runx2 and Osterix TSSs. Thus, developing strategies to restore JMJD3 expression in BMSCs should increase bone formation and possibly decrease tumor burden in MM.

ISBN: 9780438154933Subjects--Topical Terms:

518028
Biochemistry.

Decreased JMJD3 Expression in Mesenchymal Stem Cells Contributes to Long-term Suppression of Osteoblast Differentiation in Multiple Myeloma.
LDR:03622nmm a2200325 4500 001 2207940
005 20190929184015.5
008 201008s2018 ||||||||||||||||| ||eng d
020 $a 9780438154933
035 $a (MiAaPQ)AAI10827420
035 $a (MiAaPQ)iupui:10292
035 $a AAI10827420
040 $a MiAaPQ $c MiAaPQ
100 1 $a Zhao, Wei. $3 893199
245 1 0 $a Decreased JMJD3 Expression in Mesenchymal Stem Cells Contributes to Long-term Suppression of Osteoblast Differentiation in Multiple Myeloma.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2018
300 $a 139 p.
500 $a Source: Dissertations Abstracts International, Volume: 80-02, Section: B.
500 $a Publisher info.: Dissertation/Thesis.
500 $a Advisor: Roodman, Galson D.
502 $a Thesis (Ph.D.)--Indiana University - Purdue University Indianapolis, 2018.
506 $a This item must not be sold to any third party vendors.
520 $a Multiple myeloma (MM) is the most frequent cancer to involve the skeleton, with over 80% of myeloma patients developing lytic bone disease (MMBD). Importantly, MM-associated bone lesions rarely heal even when patients are in complete remission. Bone marrow stromal cells (BMSCs) isolated from MM patients have a distinct genetic profile and an impaired osteoblast (OB) differentiation capacity when compared to BMSCs from healthy donors. Utilizing an in vivo model of MMBD and patient samples, we showed that BMSCs from tumor-bearing bones failed to differentiate into OBs weeks after removal of MM cells. Both Runx2 and Osterix, the master transcription factors for OB differentiation, remained suppressed in these BMSCs. However, the molecular mechanisms for MM-induced long-term OB suppression are poorly understood. We characterized both Runx2 and Osterix promoters in murine pre-osteoblast MC4 cells by chromatin immunoprecipitation (ChIP). The transcriptional start sites (TSSs) of Runx2 and Osterix in untreated MC4 cells were co-occupied by transcriptionally active histone 3 lysine 4 tri-methylation (H3K4me3) and transcriptionally repressive histone 3 lysine 27 tri-methylation (H3K27me3), termed the "bivalent domain". These bivalent domains became transcriptionally silent with increasing H3K27me3 levels when MC4 cells were co-cultured with MM cells or treated with TNF-α, an inflammatory cytokine increased in MM bone marrow microenvironment. The increasing H3K27me3 levels induced by MM cells or TNF-α were associated with the downregulation of the H3K27 demethylase JMJD3 in MC4 cells and murine BMSCs. Knockdown of JMJD3 in MC4 cells was sufficient to inhibit OB differentiation. Further, ectopic overexpression of JMJD3 in MC4 cells partially rescued the suppression of osteoblast differentiation induced by TNF-α. We also found that pre-incubation of MC4 cells with the NF-kB inhibitor quinazoline (QNZ) before TNF-α treatment prevented the downregulation of JMJD3. In agreement with our in vitro findings, BMSCs from MM patients had persistently decreased JMJD3 expression compared to healthy BMSCs. Our findings together demonstrate that decreased JMJD3 expression in BMSCs contributes to the long-term OB suppression in MMBD by remodeling histone landscapes at the Runx2 and Osterix TSSs. Thus, developing strategies to restore JMJD3 expression in BMSCs should increase bone formation and possibly decrease tumor burden in MM.
590 $a School code: 0104.
650 4 $a Biochemistry. $3 518028
650 4 $a Medicine. $3 641104
690 $a 0487
690 $a 0564
710 2 $a Indiana University - Purdue University Indianapolis. $b Biochemistry and Molecular Biology. $3 3434940
773 0 $t Dissertations Abstracts International $g 80-02B.
790 $a 0104
791 $a Ph.D.
792 $a 2018
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=10827420